Observational studyClinical and experimental nephrology2025

SGLT2 inhibitors increase low serum magnesium levels in patients with chronic kidney disease immediately after treatment.

Kosuke Osawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.